Frontotemporal Dementia After the Bruce Willis Effect: What Neurologists Should Revisit

Frontotemporal Dementia After the Bruce Willis Effect What Neurologists Should Revisit Review Abstract The public disclosure of a frontotemporal dementia diagnosis by Bruce Willis brought unprecedented public attention to a neurodegenerative disorder that has historically remained underrecognized outside specialized neurology and memory clinics. While increased awareness has

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing

Lecanemab in Real-World Practice: What Early Alzheimer’s Patients Are Actually Experiencing Review Abstract Lecanemab represents a major milestone in the treatment of Alzheimer’s disease as the first anti amyloid monoclonal antibody to receive traditional approval from the United States Food and Drug Administration for patients with early

Frontotemporal Dementia After the Bruce Willis Effect: What Neurologists Should Revisit